Related articles

Experts share their insights on different health topics and how comprehensive healthcare solutions can treat different conditions to improve patient health.

Early Warning of Colorectal Cancer Liver Metastasis: Early Monitoring Potential of RGCC Circulating Tumor Cells

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, with a high mortality rate. Among its complications, liver metastasis is one of the most common sites for distant spread. Once liver metastasis occurs, the prognosis for the patient significantly worsens. Traditional methods for monitoring colorectal cancer metastasis mostly rely on imaging techniques, such as CT or MRI, which, while helpful in visualizing the tumor, are often limited in detecting small metastases or early-stage changes. Therefore, early detection of liver metastasis and continuous monitoring of disease progression are crucial in formulating an optimal care plan for patients.

Read More »

The Importance of Active Monitoring: How RGCC Testing Can Help Adjust Care for Cancer Patients

In the process of cancer care, advanced-stage patients often face challenges such as rapid disease progression and unstable treatment responses. For these patients, the need for dynamic monitoring is particularly urgent. Traditional monitoring methods often rely on imaging tests and biochemical markers, and the results may lag behind the actual changes in the patient’s condition. With the advancement of technology, modern testing techniques, such as RGCC’s Circulating Tumor Cell (CTC) testing, provide patients with more immediate and accurate disease assessments, helping healthcare providers adjust care plans promptly, improve treatment outcomes, and extend patients’ survival.

Read More »

Basic Assessment and Heavy Metal Burden: Optimizing Drug Metabolism

In modern medicine, drug metabolism is crucial for the success of treatment. However, exposure to heavy metals can significantly impact the drug metabolism process, which in turn affects therapeutic outcomes. Accumulation of heavy metals in the body can interfere with the function of important organs such as the liver and kidneys, which are responsible for drug metabolism and excretion. Excessive heavy metal burden can lead to either too slow or too fast drug metabolism, thus affecting drug efficacy or causing adverse reactions. Therefore, a basic assessment of heavy metal burden is essential for optimizing drug metabolism and ensuring effective treatment.

Read More »

New direction after drug resistance: CTC in vitro drug sensitivity detection helps personalized drug selection

With advancements in cancer-related care, many patients achieve favorable outcomes during initial treatments. However, over time, some patients may develop drug resistance, which presents challenges for maintaining efficacy. Drug resistance is not limited to traditional chemical drugs but can also occur in targeted therapies and immunotherapy. Selecting the appropriate treatment to address resistance has become a significant challenge in cancer care. Circulating Tumor Cell (CTC)-based drug sensitivity testing, as a new approach for personalized drug selection, provides a promising direction for overcoming drug resistance.

Read More »

Heavy Metal Burden and Liver Cancer Risk: From Detection and Assessment to Comprehensive Management

Heavy metal contamination has gradually become an undeniable health concern in modern society. Prolonged accumulation of heavy metals may have negative effects on multiple organ systems, especially the liver. As a vital detoxification organ in the body, the liver can be compromised when exposed to heavy metals over time, potentially increasing the risk of certain liver diseases, including liver cancer. This article explores the potential connection between heavy metal burden and liver cancer, and proposes strategies to reduce risk through scientific detection and comprehensive management.

Read More »

High-dose vitamin C: exploring its potential to enhance the synergy between radiotherapy and chemotherapy care

In recent years, high-dose vitamin C (VC) has received some attention in the field of cancer auxiliary care. In addition to its traditional antioxidant effects, some preliminary studies suggest that high doses of vitamin C may be associated with certain biological response markers when used in conjunction with radiological or chemical procedures. This article aims to discuss some of the preliminary observed mechanisms of action and safety considerations for use, and emphasizes that the content of this article is for reference only and should not be regarded as any form of medical advice.

Read More »

Care and protection combination: Vitamin C + selenium + glutathione

Chemotherapy is a critical component of cancer treatment for many patients, but it often brings about numerous side effects, including immune system suppression, nausea, fatigue, and cellular damage. To help alleviate these side effects and improve the quality of life for chemotherapy patients, several studies have shown the beneficial role of certain antioxidants and nutrients. Among these, the combination of Vitamin C, Selenium, and Glutathione has been recognized for its protective effects in chemotherapy patients. Below are the roles of these three components and how they work together to provide necessary protective support.

Read More »

Early Detection of Lung Cancer Through RGCC Technology

Lung cancer remains one of the most common cancers worldwide, with a high mortality rate. One of the primary challenges in lung cancer management is its late diagnosis, as early-stage lung cancer often presents with no obvious symptoms. As a result, many patients are diagnosed at an advanced stage, limiting their treatment options and reducing survival rates. While conventional screening methods such as chest X-rays and CT scans can detect certain abnormalities, they often lack the sensitivity to identify lung cancer in its earliest stages. This makes the search for more precise early detection methods essential for improving patient outcomes.

Read More »

Personalized Cancer Care Plan: How RGCC Designs It Based on Your Genetic Characteristics

With the rapid development of precision medicine and genomics, cancer treatment is moving toward a more personalized approach. Personalized cancer care plans are tailored to each patient based on their genetic background, cancer type, immune status, and other physiological factors. RGCC (Research Genetic Cancer Centre) uses advanced genetic testing technologies to help cancer patients create more accurate care plans based on their individual genetic characteristics, enhancing treatment outcomes and minimizing side effects.

Read More »